Paola Zanaga
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effectiveness, Safety and Patient-Reported Outcomes of Bulevirtide Therapy in Chronic Hepatitis Delta: Real-World Evidence From a Prospective Observational Study.
Journal: Journal of viral hepatitis
Published: January 26, 2026
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study.
Journal: Cancers
Published: February 20, 2025
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults.
Journal: Transplantation direct
Published: November 15, 2024
Incidence and Clinical Significance of Recompensation After HCV Cure.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 15, 2024
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment.
Journal: Alimentary pharmacology & therapeutics
Published: June 16, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.
Journal: Hepatology (Baltimore, Md.)
Published: November 19, 2023
Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 09, 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Journal: Hepatology communications
Published: March 14, 2023
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Journal: JHEP reports : innovation in hepatology
Published: November 07, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026